GEN Exclusives

More »

GEN News Highlights

More »
Mar 31, 2009

Mount Sinai Taps DiscoveryBioMed for Drug Discovery Programs

  • Mount Sinai School of Medicine (MSSM) is employing DiscoveryBioMed (DBM) in fee-for-service contracts covering basic drug discovery work. The agreement calls for human cell optimization, assay optimization, and drug discovery bioassays.

    Experiments have reportedly commenced on assay optimization, and pilot drug screening will begin shortly. The firm is using its expertise in the development and engineering of human cell cultures and lines from normal or diseased tissue.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »